SCHEMBL8816124

SCHEMBL8816124

Cc1ccc(/N=N/c2c(O)c(S(=O)(=O)O)cc3cc(S(=O)(=O)O)ccc23)c(C)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 3/20 1.00
▸ ALDH1A1 P00352 2/20 1.00
▸ MEN1 O00255 2/20 0.67
▸ KMT2A Q03164 2/20 0.67
▸ THRB P10828 2/20 0.67
▸ TDP1 Q9NUW8 1/20 0.67
▸ CYP1A2 P05177 3/20 0.64
▸ ENPP2 Q13822 9/20 0.64
▸ SUMO2 P61956 1/20 0.59
▸ SUMO1 P63165 1/20 0.59
▸ SENP7 Q9BQF6 1/20 0.59
▸ SENP3 Q9H4L4 1/20 0.59
▸ SENP2 Q9HC62 1/20 0.59
▸ SENP1 Q9P0U3 1/20 0.59
▸ CYP2C9 P11712 2/20 0.57
▸ HTT P42858 1/20 0.52
▸ TSHR P16473 1/20 0.47
▸ PTPRA P18433 1/20 0.47
▸ PTPRB P23467 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6846279 1.00 HIF1A (1.00) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL4068193 1.00 HIF1A (1.00) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL10622991 0.99 HIF1A (0.98) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL8947349 0.93 ALDH1A1 (0.87) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL30655205 0.87 HIF1A (0.78) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL4579446 0.87 HIF1A (0.78) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL15424240 0.86 HIF1A (0.76) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL17804082 0.86 CYP1A2 (0.76) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL6846278 0.85 ALDH1A1 (0.74) HIF1AALDH1A1MEN1KMT2ATHRB
SCHEMBL29350187 0.85 ALDH1A1 (0.74) HIF1AALDH1A1MEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090118135-A1 METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS THE BURNHAM INSTITUTE (US) 2009-05-07 — — US disclosed
US-20090118135-A1 METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS THE BURNHAM INSTITUTE (US) 2009-05-07 — — US disclosed
US-7264932-B2 Nuclease inhibitor cocktail APPLERA CORPORATION (US) 2007-09-04 — — US disclosed
US-7264932-B2 Nuclease inhibitor cocktail APPLERA CORPORATION (US) 2007-09-04 — — US disclosed
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same AMBION, INC (US) 2007-02-08 — — US disclosed
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same AMBION, INC (US) 2007-02-08 — — US disclosed
WO-1997041844-A1 COMBINATIONS OF ANGIOSTATIC COMPOUNDS ALCON LABORATORIES, INC. (US) 1997-11-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032418-A1 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same RNASE1, RNASEH1, RNASEL HIF1A 1080/4885ALDH1A1 2603/4885MEN1 2073/4885
US-20090118135-A1 METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS BCL2, BAX, BAD HIF1A 3620/4885ALDH1A1 3724/4885MEN1 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback